For the Inventor, By the Inventor

Enter assignee name

Petaluma, CA, United States of America

Dow Pharmaceutical Sciences, Inc.

USPTO Granted Patents = 48

% Expired Patents = 10.4

CIPO Patents = 2

EPO Patents = 9

Trademarks = 1

Forward Citations = 754

Loading Chart...

Loading Chart...

22 inventors (with patents filed for the assignee):

Gordon J Dow (31 out of 43 patents)

Yunik Chang (18 out of 21 patents)

Radhakrishnan Pillai (9 out of 27 patents)

4. Gareth Winckle (9 out of 11 patents)

5. Gregory T Fieldson (9 out of 18 patents)

6. Arturo Angel (5 out of 28 patents)

7. David W Osborne (5 out of 43 patents)

8. Varsha D Bhatt (5 out of 23 patents)

9. Pramod P Sarpotdar (4 out of 4 patents)

10. Nayan Desai (3 out of 6 patents)

11. Haigang Chen (3 out of 8 patents)

12. Sarmistha Basu (3 out of 3 patents)

13. Meidong Yang (3 out of 3 patents)

14. Bhaskar Chaudhuri (2 out of 9 patents)

15. Barry Calvarese (2 out of 2 patents)

Core Competencies:

Benzoyl Peroxide

Corticosteroids

Azithromycin

Efinaconazole

Kinetin

Nail Diseases

Aqueous Compositions

Skin Disorders

Controlled Release

Topical Gel

Acne Vulgaris

Moisturizing Vehicle

48 patents: Sort by Forward Citations

1. 11478498 - Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent (2022-10-25),

2. 10828369 - Compositions and methods for treating diseases of the nail (2020-11-10),

3. 10828293 - Anti-infective methods, compositions, and devices (2020-11-10),

4. 10624918 - Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent (2020-04-21),

5. 10512640 - Compositions and methods for treating diseases of the nail (2019-12-24),

6. 10478502 - Pharmaceutical formulations containing corticosteroids for topical administration (2019-11-19),

7. 10342875 - Stabilized efinaconazole compositions (2019-07-09),

8. 10245257 - Anti-infective methods, compositions, and devices (2019-04-02),

9. 10220049 - Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent (2019-03-05),

10. 10166235 - Kinetin/zeatin topical formulation (2019-01-01),

11. 10137142 - Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent (2018-11-27),

12. 10105444 - Compositions and methods for treating diseases of the nail (2018-10-23),

13. 9925194 - Kinetin/zeatin topical formulation (2018-03-27),

14. 9877955 - Compositions and methods for treating diseases of the nail (2018-01-30),

15. 9861698 - Compositions and methods for treating diseases of the nail (2018-01-09),

Dow Pharmaceutical Sciences, Inc., based in Petaluma, California, specializes in the development and manufacturing of innovative topical pharmaceutical formulations. The company focuses on a range of therapeutic areas, including anti-infective compositions and corticosteroid administration, leveraging advanced technologies to enhance drug solubility and controlled release. Their expertise extends to formulations involving benzoyl peroxide, efinaconazole, and kinetin zeatin, addressing diverse medical needs through targeted delivery systems.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

48 Patents

#6 in Petaluma, CA

#1,714 in California

#7,280 in US

#14,536 in the World

Petaluma, CA, United States of America

Dow Pharmaceutical Sciences, Inc.

Forward Citations = 754

22 inventors:

Gordon J Dow (31 out of 43 patents)

Yunik Chang (18 out of 21 patents)

Radhakrishnan Pillai (9 out of 27 patents)

4. Gareth Winckle (9 out of 11 patents)

5. Gregory T Fieldson (9 out of 18 patents)

Please report any incorrect information to [email protected]

Loading…